On-Demand CGT Formulation Webinars

  1. Enhancing Gene Editing Outcomes And Safety for Clinical Translation With Next Generation Vectors 5/6/2026

    Learn how streamlined vector backbones can improve efficiency, consistency, and expression durability when reliability matters most.

  2. A Novel Cell Selective Lentiviral Platform For CAR-T Engineering 5/4/2026

    Targeted lentiviral vectors enable rapid CAR‑T cell generation without extensive ex vivo manipulation. See how this approach demonstrates efficient in vitro and in vivo performance.

  3. Unlocking The Next Wave Of Cancer Vaccines 4/21/2026

    Discover how advanced ionizable LNP formulations and scalable manufacturing strategies can accelerate the development and clinical translation of personalized cancer vaccines.

  4. Scaling MSC Therapies: Overcoming MSC Manufacturing Risks And Barriers 4/1/2026

    Explore strategies for scaling MSC manufacturing while mitigating biological and operational risks. Learn how closed-system platforms and optimized workflows accelerate the path to commercial cell therapy.

  5. Evaluating Novel Whole Blood Preservation Methods As Alternatives To PBMC 3/22/2026

    Discover how alternative whole blood preservation methods can improve specimen stability, streamline global clinical trial logistics, and enhance immunophenotyping results.

  6. Translating Stem Cell Programs To GMP 3/4/2026

    A detailed exploration of challenges in advancing stem cell programs to GMP, highlighting strategies to control variability, strengthen process design, and support reliable clinical‑stage manufacturing.

  7. Viral Clearance Strategies For Monoclonal Antibodies And Proteins 1/30/2026

    Guidance on designing viral clearance studies using regulatory-aligned, risk‑based strategies, optimized assays, and real case examples for safe, efficient biologics development.

  8. Drug Product Development: Preclinical To Commercial 1/26/2026

    Watch a unified roadmap for drug product development, outlining phase‑appropriate studies, QTTP importance, and key requirements from preclinical stages through commercialization.

  9. Developability Assessment And Early Formulation Studies 1/26/2026

    Early developability and pre‑formulation screening build strong biophysical data, reduce late‑stage risks, support candidate selection, and streamline biologics development toward clinical success.

  10. Five Practical Considerations To Move From Concept To Clinic 12/17/2025

    Learn more about five key factors for advancing targeted in vivo LNP programs, from formulation and targeting strategies to bioanalytical readiness and scalability.